JACC. Case reports · 2026
Depressed LV Contractility as a Sentinel of Fulminant Systemic Scleroderma.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Luo Meiqi, Branch Tatianna, Vasoya Devin, Mazzoni Jennifer A
Аннотация
BACKGROUND: Depressed left ventricular (LV) contractility is rare in cardiac scleroderma. We present a case of rapidly progressive systemic scleroderma (SSc) with decreased LV function.
CASE: A previously healthy 21-year-old man presented with palpitations, weight loss, and diffuse swelling. Evaluation revealed reduced LV function, diffuse gadolinium enhancement on cardiac magnetic resonance imaging, and endomyocardial biopsy showed mast cell infiltration and early fibrosis. Despite initiation of guideline-directed medical therapy, cardiac function deteriorated over 1 month. Further workup established SSc. Cyclophosphamide was initiated; however, the patient succumbed to a saddle pulmonary embolism 2 months after diagnosis.
DISCUSSION: LV systolic dysfunction in SSc signals advanced myocardial involvement and demands urgent recognition, as deterioration may occur within a narrow therapeutic window. Early detection and intervention are critical to improving outcomes in this vulnerable subset of patients.
TAKE-HOME MESSAGE: Patients with depressed LV contractility in cardiac scleroderma should receive prompt cardiac testing and treatment.
CASE: A previously healthy 21-year-old man presented with palpitations, weight loss, and diffuse swelling. Evaluation revealed reduced LV function, diffuse gadolinium enhancement on cardiac magnetic resonance imaging, and endomyocardial biopsy showed mast cell infiltration and early fibrosis. Despite initiation of guideline-directed medical therapy, cardiac function deteriorated over 1 month. Further workup established SSc. Cyclophosphamide was initiated; however, the patient succumbed to a saddle pulmonary embolism 2 months after diagnosis.
DISCUSSION: LV systolic dysfunction in SSc signals advanced myocardial involvement and demands urgent recognition, as deterioration may occur within a narrow therapeutic window. Early detection and intervention are critical to improving outcomes in this vulnerable subset of patients.
TAKE-HOME MESSAGE: Patients with depressed LV contractility in cardiac scleroderma should receive prompt cardiac testing and treatment.